Literature DB >> 23114271

Risk factors for atrial fibrillation recurrence: a literature review.

Enrico Vizzardi1, Antonio Curnis, Maria G Latini, Francesca Salghetti, Elena Rocco, Laura Lupi, Riccardo Rovetta, Filippo Quinzani, Ivano Bonadei, Luca Bontempi, Antonio D'Aloia, Livio Dei Cas.   

Abstract

Atrial fibrillation is the most common arrhythmia managed in clinical practice and it is associated with an increased risk of mortality, stroke and peripheral embolism. Unfortunately, the incidence of atrial fibrillation recurrence ranges from 40 to 50%, despite the attempts of electrical cardioversion and the administration of antiarrhythmic drugs. In this review, the literature data about predictors of atrial fibrillation recurrence are highlighted, with special regard to clinical, therapeutic, biochemical, ECG and echocardiographic parameters after electrical cardioversion and ablation. Identifying predictors of success in maintaining sinus rhythm after cardioversion or ablation may allow a better selection of patients to undergo these procedures. The aim is to reduce healthcare costs and avoid exposing patients to unnecessary procedures and related complications. Recurrent atrial fibrillation depends on a combination of several parameters and each patient should be individually assessed for such a risk of recurrence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23114271     DOI: 10.2459/JCM.0b013e328358554b

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  22 in total

Review 1.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

2.  Use of acoustic cardiography immediately following electrical cardioversion to predict relapse of atrial fibrillation.

Authors:  Paul Erne; Therese J Resink; Andrea Mueller; Michael Coslovsky; Richard Kobza; David Conen; Peter Bauer; Patricia Arand
Journal:  J Atr Fibrillation       Date:  2017-06-30

3.  Echocardiographic predictors of atrial fibrillation recurrence after catheter ablation: A literature review.

Authors:  Aleksandra Liżewska-Springer; Alicja Dąbrowska-Kugacka; Ewa Lewicka; Łukasz Drelich; Tomasz Królak; Grzegorz Raczak
Journal:  Cardiol J       Date:  2018-06-20       Impact factor: 2.737

4.  Increased left atrial size is associated with higher atrial fibrillation recurrence in patients treated with antiarrhythmic medications.

Authors:  Saarang Mulukutla; Andrew D Althouse; Sandeep K Jain; Samir Saba
Journal:  Clin Cardiol       Date:  2018-06-07       Impact factor: 2.882

5.  Echocardiographic assessment of left atrial morphology and function to predict maintenance of sinus rhythm after electrical cardioversion in patients with non-valvular persistent atrial fibrillation and normal function or mild dysfunction of left ventricle.

Authors:  Paweł Wałek; Janusz Sielski; Katarzyna Starzyk; Iwona Gorczyca; Joanna Roskal-Wałek; Beata Wożakowska-Kapłon
Journal:  Cardiol J       Date:  2019-07-17       Impact factor: 2.737

6.  A meta-analysis on Omega-3 supplements in preventing recurrence of atrial fibrillation.

Authors:  Ying Jiang; Hui Ching Tan; Wilson Wai San Tam; Toon Wei Lim; Wenru Wang
Journal:  Oncotarget       Date:  2017-12-30

7.  A self-management support intervention for patients with atrial fibrillation: a randomized controlled pilot trial.

Authors:  Stefan Jobst; Lynn Leppla; Stefan Köberich
Journal:  Pilot Feasibility Stud       Date:  2020-06-18

8.  Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation.

Authors:  Kun Zuo; Jing Li; Kuibao Li; Chaowei Hu; Yuanfeng Gao; Mulei Chen; Roumu Hu; Ye Liu; Hongjie Chi; Hongjiang Wang; Yanwen Qin; Xiaoyan Liu; Shichao Li; Jun Cai; Jiuchang Zhong; Xinchun Yang
Journal:  Gigascience       Date:  2019-06-01       Impact factor: 6.524

9.  The Impact of Repeated Cardioversions for Atrial Fibrillation on Stroke, Hospitalizations, and Catheter Ablation Outcomes.

Authors:  Victoria Jacobs; Heidi T May; Tami L Bair; Brian G Crandall; Michael J Cutler DO; John D Day; Viet Le; Charles Mallender; Jeffrey S Osborn; J Peter Weiss; T Jared Bunch
Journal:  J Atr Fibrillation       Date:  2019-04-30

Review 10.  Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation.

Authors:  David Bode; Lukas Semmler; Christian U Oeing; Alessio Alogna; Gabriele G Schiattarella; Burkert M Pieske; Frank R Heinzel; Felix Hohendanner
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.